Research & Development



  唯有如此,才能選拔出真正的可以縱橫朝堂,掌控國家的蓋世奇才出來。   雲瑯端起茶杯喝口茶道︰“是可以過安穩日子了,只是,從今後你我休想觸踫一星半點的權力。也就是說,你我的時代已經結束了。”色播影音先锋   如果兩人不對付了,是可以打架的,一旦分出勝負之後,輸的人很倒霉,不但要听贏家的話一次,這頓打也是白挨。色妊阁伊人在线   于是呢,當地的太守梁贊就打著販賣牛羊的名頭,開起來了市場,實際上呢,依舊在交易鐵器以及鐵礦石。   曹襄的頭發變得斑白,留在長安的一個月時間里,對他來說就是一場大煎熬。伊人在线猫   “何為商業社會?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo